Unknown

Dataset Information

ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.


ABSTRACT: BACKGROUND:Rare prostate carcinomas aberrantly express p63 and have an immunophenotype intermediate between basal and luminal cells. Here, we performed gene expression profiling on p63-expressing prostatic carcinomas and compared them to usual-type adenocarcinoma. We identify ETS2 as highly expressed in p63-expressing prostatic carcinomas and benign prostate basal cells, with lower expression in luminal cells and primary usual-type adenocarcinomas. METHODS:A total of 8 p63-expressing prostate carcinomas at radical prostatectomy were compared to 358 usual-type adenocarcinomas by gene expression profiling performed on formalin fixed paraffin embedded tumor tissue using Affymetrix 1.0 ST microarrays. Correlation between differentially expressed genes and TP63 expression was performed in 5239

SUBMITTER: Torres A 

PROVIDER: S-EPMC6818503 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature